Search by year - Any -2024202320222021202020192018201720162015 18 May 2017 Study demonstrating high performance of Idylla™ liquid biopsy RAS tests to be presented at ASCO Annual Meeting Non-regulated information 15 March 2017 Biocartis receives grant for development of a fully automated MSI test Non-regulated information 9 March 2017 Study using Biocartis’ liquid biopsy BRAF assay shows new option for retreatment of melanoma patients Non-regulated information 2 March 2017 Important milestone in Biocartis-Merck collaboration with launch of second liquid biopsy assay Non-regulated information 22 December 2016 Biocartis and Amgen sign a RAS Biomarker Testing Collaboration in Europe Inside information Regulated information 22 December 2016 Biocartis submits 510(k) file with US FDA for Idylla Platform Non-regulated information 15 December 2016 CE-marking Idylla NRAS-BRAF Mutation Test completes offering of metastatic colorectal cancer tests for clinical use on Idylla Platform Non-regulated information 7 December 2016 Biocartis launches second liquid biopsy assay Non-regulated information 11 October 2016 AstraZeneca Comparative Study confirms Best-In-Class Status of Idylla™ KRAS Mutation Detection Technology Non-regulated information 7 October 2016 Three Idylla™ Test Performance Studies to be presented at Esmo Oncology Conference Non-regulated information Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Next page Next › Last page Last »